BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 32431276)

  • 1. Nationwide Remapping of
    Ruberanziza E; Wittmann U; Mbituyumuremyi A; Mutabazi A; Campbell CH; Colley DG; Fleming FM; Ortu G; van Dam GJ; Umulisa I; Tallant J; Kabera M; Semakula M; Corstjens PLAM; Munyaneza T; Lancaster W; Mbonigaba JB; Clements MN
    Am J Trop Med Hyg; 2020 Jul; 103(1):315-324. PubMed ID: 32431276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Latent class analysis to evaluate performance of point-of-care CCA for low-intensity Schistosoma mansoni infections in Burundi.
    Clements MN; Corstjens PLAM; Binder S; Campbell CH; de Dood CJ; Fenwick A; Harrison W; Kayugi D; King CH; Kornelis D; Ndayishimiye O; Ortu G; Lamine MS; Zivieri A; Colley DG; van Dam GJ
    Parasit Vectors; 2018 Feb; 11(1):111. PubMed ID: 29475457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accuracy of Two Circulating Antigen Tests for the Diagnosis and Surveillance of Schistosoma mansoni Infection in Low-Endemicity Settings of Côte d'Ivoire.
    Assaré RK; Tra-Bi MI; Coulibaly JT; Corstjens PLAM; Ouattara M; Hürlimann E; van Dam GJ; Utzinger J; N'Goran EK
    Am J Trop Med Hyg; 2021 Jul; 105(3):677-683. PubMed ID: 34280143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mapping Schistosoma mansoni endemicity in Rwanda: a critical assessment of geographical disparities arising from circulating cathodic antigen versus Kato-Katz diagnostics.
    Clark NJ; Umulisa I; Ruberanziza E; Owada K; Colley DG; Ortu G; Campbell CH; Ruzindana E; Lancaster W; Mbonigaba JB; Mbituyumuremyi A; Fenwick A; Soares Magalhaes RJ; Turate I
    PLoS Negl Trop Dis; 2019 Sep; 13(9):e0007723. PubMed ID: 31568504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of single versus four repeated doses of praziquantel against Schistosoma mansoni infection in school-aged children from Côte d'Ivoire based on Kato-Katz and POC-CCA: An open-label, randomised controlled trial (RePST).
    Hoekstra PT; Casacuberta-Partal M; van Lieshout L; Corstjens PLAM; Tsonaka R; Assaré RK; Silué KD; Meité A; N'Goran EK; N'Gbesso YK; Amoah AS; Roestenberg M; Knopp S; Utzinger J; Coulibaly JT; van Dam GJ
    PLoS Negl Trop Dis; 2020 Mar; 14(3):e0008189. PubMed ID: 32196506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparing the performance of circulating cathodic antigen and Kato-Katz techniques in evaluating Schistosoma mansoni infection in areas with low prevalence in selected counties of Kenya: a cross-sectional study.
    Okoyo C; Simiyu E; Njenga SM; Mwandawiro C
    BMC Public Health; 2018 Apr; 18(1):478. PubMed ID: 29642875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of circulating cathodic antigen (CCA) urine-cassette assay as a survey tool for Schistosoma mansoni in different transmission settings within Bugiri District, Uganda.
    Adriko M; Standley CJ; Tinkitina B; Tukahebwa EM; Fenwick A; Fleming FM; Sousa-Figueiredo JC; Stothard JR; Kabatereine NB
    Acta Trop; 2014 Aug; 136():50-7. PubMed ID: 24727052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Performance of an Ultra-Sensitive Assay Targeting the Circulating Anodic Antigen (CAA) for Detection of
    Sousa MS; van Dam GJ; Pinheiro MCC; de Dood CJ; Peralta JM; Peralta RHS; Daher EF; Corstjens PLAM; Bezerra FSM
    Front Immunol; 2019; 10():682. PubMed ID: 31019510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Countrywide Reassessment of
    Ortu G; Ndayishimiye O; Clements M; Kayugi D; Campbell CH; Lamine MS; Zivieri A; Magalhaes RS; Binder S; King CH; Fenwick A; Colley DG; Jourdan PM
    Am J Trop Med Hyg; 2017 Mar; 96(3):664-673. PubMed ID: 28115675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the Point-of-Care Circulating Cathodic Antigen Assay for Monitoring Mass Drug Administration in a Schistosoma mansoni Control Program in Western Kenya.
    Straily A; Kavere EA; Wanja D; Wiegand RE; Montgomery SP; Mwaki A; Eleveld A; Secor WE; Odiere MR
    Am J Trop Med Hyg; 2021 Nov; 106(1):303-311. PubMed ID: 34749308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sensitivity of the Point-of-Care Circulating Cathodic Antigen Urine Cassette Test for Diagnosis of
    Assaré RK; Tra MBI; Ouattara M; Hürlimann E; Coulibaly JT; N'Goran EK; Utzinger J
    Am J Trop Med Hyg; 2018 Dec; 99(6):1567-1572. PubMed ID: 30277203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Field assessment in Cameroon of a reader of POC-CCA lateral flow strips for the quantification of Schistosoma mansoni circulating cathodic antigen in urine.
    Mewamba EM; Tiofack AAZ; Kamdem CN; Ngassam RIK; Mbagnia MCT; Nyangiri O; Noyes H; Womeni HM; Njiokou F; Simo G
    PLoS Negl Trop Dis; 2021 Jul; 15(7):e0009569. PubMed ID: 34260610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improvement of POC-CCA Interpretation by Using Lyophilization of Urine from Patients with Schistosoma mansoni Low Worm Burden: Towards an Elimination of Doubts about the Concept of Trace.
    Coelho PM; Siqueira LM; Grenfell RF; Almeida NB; Katz N; Almeida Á; Carneiro NF; Oliveira E
    PLoS Negl Trop Dis; 2016 Jun; 10(6):e0004778. PubMed ID: 27326453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluating a point-of-care circulating cathodic antigen test (POC-CCA) to detect Schistosoma mansoni infections in a low endemic area in north-eastern Brazil.
    Bezerra FSM; Leal JKF; Sousa MS; Pinheiro MCC; Ramos AN; Silva-Moraes V; Katz N
    Acta Trop; 2018 Jun; 182():264-270. PubMed ID: 29526480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of urine-circulating cathodic antigen (Urine-CCA) cassette test for the detection of Schistosoma mansoni infection in areas of moderate prevalence in Ethiopia.
    Erko B; Medhin G; Teklehaymanot T; Degarege A; Legesse M
    Trop Med Int Health; 2013 Aug; 18(8):1029-35. PubMed ID: 23590255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Accuracy of urine circulating cathodic antigen test for the diagnosis of Schistosoma mansoni in preschool-aged children before and after treatment.
    Coulibaly JT; N'Gbesso YK; Knopp S; N'Guessan NA; Silué KD; van Dam GJ; N'Goran EK; Utzinger J
    PLoS Negl Trop Dis; 2013; 7(3):e2109. PubMed ID: 23556011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of circulating cathodic antigen (CCA) urine-tests for diagnosis of Schistosoma mansoni infection in Cameroon.
    Tchuem Tchuenté LA; Kueté Fouodo CJ; Kamwa Ngassam RI; Sumo L; Dongmo Noumedem C; Kenfack CM; Gipwe NF; Nana ED; Stothard JR; Rollinson D
    PLoS Negl Trop Dis; 2012; 6(7):e1758. PubMed ID: 22860148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High Egg Reduction Rate but poor clearance of Circulating Cathodic Antigen three weeks after Praziquantel treatment among school children on Ijinga Island, north-western Tanzania.
    Mazigo HD; Fuss A; Mueller A
    Acta Trop; 2021 Jun; 218():105871. PubMed ID: 33647243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sensitivity and specificity of multiple Kato-Katz thick smears and a circulating cathodic antigen test for Schistosoma mansoni diagnosis pre- and post-repeated-praziquantel treatment.
    Lamberton PH; Kabatereine NB; Oguttu DW; Fenwick A; Webster JP
    PLoS Negl Trop Dis; 2014 Sep; 8(9):e3139. PubMed ID: 25211217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A five-country evaluation of a point-of-care circulating cathodic antigen urine assay for the prevalence of Schistosoma mansoni.
    Colley DG; Binder S; Campbell C; King CH; Tchuem Tchuenté LA; N'Goran EK; Erko B; Karanja DMS; Kabatereine NB; van Lieshout L; Rathbun S
    Am J Trop Med Hyg; 2013 Mar; 88(3):426-432. PubMed ID: 23339198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.